Andrew Dreyfus

Andrew Dreyfus is a health care executive and expert in health system change.  He served from 2010 to 2022 as President and Chief Executive Officer for Blue Cross Blue Shield of Massachusetts (BCBSMA), a plan with over $9 billion in revenue and three million members.  Under his leadership, BCBSMA was known as an innovator on payment models, quality improvement, mental health, and health equity. 

Andrew joined BCBSMA in 2005 as Executive Vice President of Health Care Services, where he led the creation of the Alternative Quality Contract, one of the largest commercial payment reform programs in the nation.  He previously served as founding President of the Blue Cross Blue Shield of Massachusetts Foundation, where he oversaw the initiative that led to the passage of The Massachusetts 2006 Health Reform Law, which later became the model for the Affordable Care Act.

Andrew is an Adjunct Lecturer in health policy and management at Harvard University’s T.H.Chan School of Public Health, an Expert-in-Residence at United States of Care, and a Senior Fellow at the Institute for Healthcare Improvement.  His writing has appeared in The Boston Globe, The Washington Post, STAT, Politico, and The Hill.

Andrew serves on the boards of Ironwood Pharmaceuticals, The Joint Commission, The National Quality Forum, Alto Neuroscience, Octave, and the BCBSMA Foundation, which he chairs.  He serves on the advisory boards of Ariadne Labs, Arsenal Capital Partners, Vale Health, SemCap Health, Hopebridge, Parents for Peace, and the Leonard Schaeffer Center for Health Policy and Economics at the University of Southern California. 

Over the last two decades, Andrew has helped lead the creation of several collaborative health organizations in Massachusetts, including the Schwartz Center for Compassionate Care, RIZE Massachusetts, Massachusetts Health Quality Partners, and the Massachusetts Coalition for Serious Illness Care.

Prior to Blue Cross, Andrew was Executive Vice President of the Massachusetts Hospital Association and held senior health and regulatory positions in Massachusetts state government.